DSP p.Val495Met
c.1483G>A · rs372014020 · VCV228635
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9536 | likely pathogenic · top 10% in DSP |
|---|---|---|
| REVEL | 0.719 | pathogenic-leaning |
| SaProt | LLR -10.18 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 29 kb · p 0.14 · regional, not allelic |
| Overall | ||
| CADD | 30.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.409% | 245 |
| Remaining individualsnot grpmax-eligible | 0.0336% | 2,976 |
| European (non-Finnish)grpmax | 0.00254% | 39,334 |
| East Asian | 0.00223% | 44,896 |
| South Asian | 0.0022% | 45,543 |
| Admixed American | 0.00167% | 60,018 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DSP
- Protein
- p.Val495Met
- Coding
- c.1483G>A
- MANE Select
- NM_004415
- dbSNP
- rs372014020
- Type
- single nucleotide variant
- Location
- chr6:7569249 (GRCh38)
- Gene constraint
- LOEUF 0.443 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Residue 495
- a β-strand; the 'globular 1' region; the 'interaction with mapre1' region; the 'interaction with jup and pkp2' region; the sh3 domain; a UniProt-annotated variant site (in arvd8; uncertain significance); a UniProt-annotated variant site (in dcwhkta; uncertain significance); a UniProt-annotated variant site (in arvd8; likely pathogenic; results in an unstable protein that forms perinuclear aggregates); a UniProt-annotated variant site (in arvd8 and dcwhkta; uncertain significance); a UniProt-annotated variant site (in arvd8)
Disease context
Cardiovascular phenotype — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: cardiomyopathyventricular tachycardiaarrhythmogenic cardiomyopathy with wooly hair and keratodermaarrhythmogenic right ventricular dysplasia 8lethal acantholytic epidermolysis bullosawoolly hair-skin fragility syndrome
Similar variants
- DSP p.Val495Ala Uncertain significance ★★ ⚠ same residue
- DSP p.Val495Leu Uncertain significance ★★ same residue
- DSP p.Val495= Likely benign ★★ same residue
- DSP p.Val495Gly Uncertain significance ★ ⚠ same residue
- DSP p.Val495Phe Uncertain significance ★★ same residue
- DSP c.1141-2A>T Likely pathogenic ★★ same condition
- DSP c.1266+2T>C Likely pathogenic ★★ same condition
- DSP c.1574+1G>A Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dsp-p-val495met (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown